Table 3.
Patient Population | Age Group | Estimated Average Monthly Change in Absolute Value of TPR | |||||
---|---|---|---|---|---|---|---|
Initial Period of Effective IRS, | Sustained Period of Effective IRS, | 4–18 Months After IRS Discontinued, | |||||
September 2010–February 2011 | March 2011August 2014 | September 2014–November 2015 | |||||
Δ TPR (95% CI)a | P Value | Δ TPR (95% CI)a | P Value | Δ TPR (95% CI)a | P Value | ||
Outpatient surveillance | <5 years | –5.84% (–7.44% to –4.24%) | <.001 | –0.40% (–0.64% to –0.16%) | .002 | 3.29% (2.01% to 4.57%) | <.001 |
≥5 years | –3.06% (–4.89% to –1.24%) | .001 | –0.41% (–0.61% to –0.21%) | <.001 | 2.78% (2.01% to 3.54%) | <.001 | |
Inpatient surveillanceb | ≤13 years | N/A | N/A | 5.66% (3.22% to 8.10%) | <.001 |
Abbreviations: CI, confidence interval; IRS, indoor residual spraying of insecticide; N/A, not applicable; TPR, test positivity rate.
aAdjusted for rainfall with a 1-month lag and proportion of laboratory testing based on microscopy vs rapid diagnostic test.
bInpatient surveillance began June 2011.